
AME · NYSE
Consensus is Buy across 13 analysts, with a reported mean price target of $260. The supplied consensus does not provide a low or high target, so target clustering and the width of the range cannot be established. It also names no individual analysts, leaving the most and least bullish views unidentified. No rating or price-target revisions are explicitly reported during the past week. The substantive disagreement behind the target distribution therefore cannot be determined from the evidence. The available research instead centers on AMETEK’s second-quarter earnings beat, with earnings 5.03% above estimates and revenue 4.50% above estimates, but it does not show how analysts translated those results into revised forecasts.